BioNexus Gene Lab (BGLC) Other Gross PP&E Adjustments (2019 - 2026)

BioNexus Gene Lab's Other Gross PP&E Adjustments history runs 8 years deep, the most recent figure standing at $2.5 million for Q1 2026.

• In Q1 2026, Other Gross PP&E Adjustments rose 6.14% year-over-year to $2.5 million; the TTM figure through Mar 2026 stood at $2.5 million (up 6.14% YoY), while the FY2025 annual figure was $2.5 million, up 10.24% from the prior year.
• Other Gross PP&E Adjustments came in at $2.5 million for Q1 2026 at BioNexus Gene Lab, down from $2.5 million in the prior quarter.
• In the past five years, Other Gross PP&E Adjustments ranged from a high of $2.5 million in Q4 2025 to a low of -$55026.0 in Q4 2022.
• A 5-year average of $2.0 million and a median of $2.3 million in 2023 frame the typical range for Other Gross PP&E Adjustments.
• On a YoY basis, Other Gross PP&E Adjustments climbed as much as 5157.05% in 2022 and fell as far as 102.54% in 2022.
• BioNexus Gene Lab's Other Gross PP&E Adjustments stood at -$55026.0 in 2022, then jumped by 4198.2% to $2.3 million in 2023, then gained by 1.59% to $2.3 million in 2024, then advanced by 10.24% to $2.5 million in 2025, then dropped by 2.87% to $2.5 million in 2026.
• According to Business Quant data, Other Gross PP&E Adjustments over the past three periods registered $2.5 million, $2.5 million, and $2.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison